SOFIE

company

About

SOFIE is a molecular imaging company focused on empowering people with new PET technologies.

  • 251 - 500

Details

Last Funding Type
Grant
Last Funding Money Raised
$5M
Industries
Biotechnology,Life Science,Manufacturing,Medical Device,Pharmaceutical
Founded date
Jan 1, 2008
Number Of Employee
251 - 500
Operating Status
Active

SOFIE brings that vision to life by increasing the adoption and application diversity of theranostics by removing the cost and complexity traditionally associated with the technology. With a full line of imaging and radiochemistry systems and a premier radiopharmacy network and contract manufacturing organization to supply novel agents for diagnosis and therapy, the company is dedicated to improving patient health.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$11.50M
SOFIE has raised a total of $11.50M in funding over 2 rounds. Their latest funding was raised on Oct 5, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 5, 2018 Grant $5M 1 National Institutes of Health Detail
Oct 17, 2014 Grant $1.50M 1 Detail
Oct 15, 2013 Series A $5M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
SOFIE is funded by 2 investors. National Institutes of Health and MRM Capital are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
MRM Capital Grant